Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine-rich coiled-coil 1 pseudogene (LOC100419917, ENSG00000288437) is a member of the human genome's large family of pseudogenes. Pseudogenes are genetic elements that resemble protein-coding genes but are generally nonfunctional due to accumulated mutations, truncations, or lack of necessary regulatory sequences. They do not produce functional proteins, though, in rare cases, their transcriptional products may play roles in gene regulation, especially where overlapping with long non-coding RNAs. However, there is no evidence in the scientific literature or genetic databases that this specific pseudogene encodes a functional product or acts as a drug or therapeutic target[1][3]. Summary of main points: This entry is a pseudogene and not a true protein-coding gene or therapeutic target, so it should not be listed as a receptor or druggable entity. It is mainly referenced as a non-coding element in genome annotation resources and pseudogene catalogs, and there are no known drugs, biomarkers, or explicit safety concerns associated with it[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-rich coiled-coil 1 pseudogene.